/
/
/

Glenmark Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,454.50
Volume (₹)1.13 L
High (₹)2,454.50
Upper Circuit2,704.90
Low (₹)2,422.70
Lower Circuit2,213.10
Prev Close2,459.00
52W High (₹)2,537.60
Price2,435.80
52W Low (₹)1,792.60

Share Market Cap & Key Ratios Overview

M.Cap (₹)69393.40 Cr
Div. Yield (%)0.10
PE Ratio38.60
Debt to Equity0.00
Price to Book5.75
Book Value371.30
EPS (TTM)63.70
Face Value1.00
ROE (%)14.10

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
GLENMARKNSE
LTP
1W Low
1W High
Market cap (₹)
1904.2-15.8 (-0.82%)
1903.10
1984.80
4,56,833Cr
9180.5-58.5 (-0.63%)
9087
9467
2,45,426Cr
4912.5-137.5 (-2.72%)
4886.50
5066
1,87,320Cr
1136.2-54.8 (-4.60%)
1125.10
1187
1,13,217Cr
1391-32.5 (-2.28%)
1376.70
1426.10
1,12,212Cr
1857-81.5 (-4.20%)
1811.70
1949
1,01,155Cr
2123.2-48.3 (-2.22%)
2118.10
2192
97,626Cr
2352.6-30.3 (-1.27%)
2341.20
2419.20
96,859Cr
1164.2-13.8 (-1.17%)
1154.40
1179.90
96,406Cr
1652.5+7.2 (0.44%)
1622.60
1717
93,614Cr
2435.8-79.2 (-3.15%)
2420
2532.40
69,393Cr

Key Highlights of Glenmark Pharmaceuticals Ltd Balance Sheet

Glenmark Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹28.22Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹28.22Cr, and the reserves and surplus of the company is ₹24117Cr.

The company has its non-current liabilities with total liabilities of ₹34216.1Cr as of 2026-03-31.

The current liabilities are ₹3669.03Cr as of 2026-03-31. At the same time, current assets are ₹6095.1Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15202.2Cr and tangible assets of ₹2027.9Cr, provided in the Glenmark Pharmaceuticals Ltd financial statements.